CorMedix, Inc. (CRMD)
8.28
+0.08
(+0.98%)
USD |
NASDAQ |
Aug 24, 16:00
8.30
+0.02
(+0.24%)
After-Hours: 20:00
CorMedix Price : 8.28 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 8.28 | 8.495 | 8.18 | 8.28 | 1.012M |
| Aug 21, 2026 | 8.29 | 8.41 | 8.155 | 8.20 | 1.497M |
| Aug 20, 2026 | 8.49 | 8.545 | 8.19 | 8.23 | 1.006M |
| Aug 19, 2026 | 8.30 | 8.53 | 8.11 | 8.52 | 1.467M |
| Aug 18, 2026 | 7.71 | 8.27 | 7.71 | 8.17 | 2.033M |
| Aug 17, 2026 | 7.55 | 8.11 | 7.480 | 7.67 | 2.174M |
| Aug 14, 2026 | 8.05 | 8.198 | 7.46 | 7.54 | 2.701M |
| Aug 13, 2026 | 8.39 | 8.98 | 7.76 | 8.14 | 6.070M |
| Aug 12, 2026 | 7.30 | 7.31 | 7.10 | 7.10 | 1.353M |
| Aug 11, 2026 | 7.60 | 7.62 | 7.25 | 7.30 | 1.182M |
| Aug 10, 2026 | 7.40 | 7.55 | 7.31 | 7.53 | 842650.0 |
| Aug 07, 2026 | 7.58 | 7.585 | 7.395 | 7.44 | 740966.0 |
| Aug 06, 2026 | 7.43 | 7.52 | 7.38 | 7.51 | 702375.0 |
| Aug 05, 2026 | 7.52 | 7.57 | 7.37 | 7.41 | 615544.0 |
| Aug 04, 2026 | 7.60 | 7.66 | 7.48 | 7.52 | 651739.0 |
| Aug 03, 2026 | 7.60 | 7.635 | 7.40 | 7.55 | 856106.0 |
| Jul 31, 2026 | 7.49 | 7.55 | 7.30 | 7.53 | 637871.0 |
| Jul 30, 2026 | 7.28 | 7.585 | 7.23 | 7.49 | 1.183M |
| Jul 29, 2026 | 7.36 | 7.432 | 7.13 | 7.19 | 1.362M |
| Jul 28, 2026 | 7.60 | 7.69 | 7.27 | 7.35 | 1.252M |
| Jul 27, 2026 | 8.00 | 8.12 | 7.58 | 7.60 | 1.184M |
| Jul 24, 2026 | 8.07 | 8.085 | 7.83 | 7.87 | 625291.0 |
| Jul 23, 2026 | 7.85 | 8.072 | 7.76 | 8.05 | 698512.0 |
| Jul 22, 2026 | 8.18 | 8.195 | 7.86 | 7.94 | 860115.0 |
| Jul 21, 2026 | 7.82 | 8.21 | 7.82 | 8.19 | 1.038M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Innoviva, Inc. | 21.03 |
| Zevra Therapeutics, Inc. | 11.65 |
| Filana Therapeutics, Inc. | 0.93 |
| Eloxx Pharmaceuticals, Inc. | 19.99 |
| Cannabis Global, Inc. | 0.0001 |
Price Related Metrics
| PE Ratio | 3.934 |
| PS Ratio | 1.637 |
| PEG Ratio | 0.0216 |
| Price to Book Value | 1.396 |
| Price to Free Cash Flow | 3.026 |
| Earnings Yield | 25.42% |
| Market Cap | 643.08M |
| PEGY Ratio | 0.0216 |
| Operating PE Ratio | 3.487 |
| Normalized PE Ratio | 3.760 |